FR2558837B1
(fr)
*
|
1984-01-26 |
1986-06-27 |
Sanofi Sa |
Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant
|
PH27078A
(en)
*
|
1984-12-21 |
1993-02-01 |
Procter & Gamble |
Pharmaceutical compositions containing geminal diphosphonates
|
IL77243A
(en)
*
|
1984-12-21 |
1996-11-14 |
Procter & Gamble |
Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
|
US5641762A
(en)
*
|
1985-05-02 |
1997-06-24 |
Research Corporation Technologies, Inc. |
Bone targeted inhibitors of carbonic anhydrase
|
US4761406A
(en)
*
|
1985-06-06 |
1988-08-02 |
The Procter & Gamble Company |
Regimen for treating osteoporosis
|
US4902679A
(en)
*
|
1985-12-13 |
1990-02-20 |
Norwich Eaton Pharmaceuticals, Inc. |
Methods of treating diseases with certain geminal diphosphonates
|
DE3770982D1
(de)
*
|
1986-04-24 |
1991-08-01 |
Fujisawa Pharmaceutical Co |
Diphosphonsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel.
|
IL84731A0
(en)
*
|
1986-12-19 |
1988-05-31 |
Norwich Eaton Pharma |
Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
|
KR880011136A
(ko)
*
|
1987-03-11 |
1988-10-26 |
모리오까 시게오 |
아졸- 아미노메틸렌 비스포스폰산 유도체
|
IL86951A
(en)
*
|
1987-07-06 |
1996-07-23 |
Procter & Gamble Pharma |
Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
|
DE3805663A1
(de)
*
|
1988-02-24 |
1989-09-07 |
Henkel Kgaa |
Oxaalkanpolyphosphonsaeuren, ihre verwendung als thresholder sowie diese verbindungen enthaltende, komplexierend wirkende zusammensetzungen
|
CH675422A5
(el)
*
|
1988-03-31 |
1990-09-28 |
Symphar Sa |
|
FR2629716B1
(fr)
*
|
1988-04-07 |
1991-07-19 |
Sanofi Sa |
Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
|
DE3822650A1
(de)
*
|
1988-07-05 |
1990-02-01 |
Boehringer Mannheim Gmbh |
Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
DE68926310T2
(de)
*
|
1988-11-01 |
1996-10-24 |
Arch Dev Corp |
Verfahren zur abtrennung von metallischen ionen mit phosphonsäuren als complexbildner
|
US5154843A
(en)
*
|
1989-02-08 |
1992-10-13 |
The Lubrizol Corporation |
Hydroxyalkane phosphonic acids and derivatives thereof and lubricants containing the same
|
PH26923A
(en)
*
|
1989-03-08 |
1992-12-03 |
Ciba Geigy |
N-substituted amino alkanediphosphonic acids
|
US5220021A
(en)
*
|
1989-04-03 |
1993-06-15 |
The Upjohn Company |
Geminal bisphosphonic acids and derivatives as anti-arthritic agents
|
JPH0377894A
(ja)
*
|
1989-08-18 |
1991-04-03 |
Toray Ind Inc |
メチレンジホスホン酸化合物
|
DE69023844T2
(de)
*
|
1989-09-06 |
1996-06-20 |
Merck & Co Inc |
Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren.
|
DE59107135D1
(de)
*
|
1990-01-18 |
1996-02-08 |
Ciba Geigy Ag |
Phoshponsäure- und Thionophosphonsäure-Derivate
|
IE912115A1
(en)
*
|
1990-06-25 |
1992-01-01 |
Takeda Chemical Industries Ltd |
Bisphosphonic acid derivatives, their production and use
|
ATE120753T1
(de)
*
|
1990-08-21 |
1995-04-15 |
Upjohn Co |
Bisphosphonsäurederivate als antiarthritische mittel.
|
DK0561948T3
(da)
*
|
1990-12-07 |
1995-08-21 |
Upjohn Co |
Phosphonsyrederivater, der kan anvendes som antiinflammatoriske midler
|
ATE133677T1
(de)
*
|
1990-12-19 |
1996-02-15 |
Takeda Chemical Industries Ltd |
Bisphosphonsäurederivate, ihre produktion und ihre verwendung
|
IT1244698B
(it)
*
|
1991-02-01 |
1994-08-08 |
Gentili Ist Spa |
Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
|
DE69224830D1
(en)
*
|
1991-06-19 |
1998-04-23 |
Upjohn Co |
Dialkyl (dialkoxyphosphinyl)methyl phosphate als antientzündungsmittel
|
EP0521622B1
(en)
*
|
1991-07-03 |
1997-08-13 |
PHARMACIA & UPJOHN COMPANY |
Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories
|
ES2114946T3
(es)
*
|
1991-09-05 |
1998-06-16 |
Toray Industries |
Derivado de acido metanodifosfonico, su produccion y uso medicinal.
|
JPH06172372A
(ja)
*
|
1991-11-06 |
1994-06-21 |
Takeda Chem Ind Ltd |
スクアレン合成酵素阻害剤およびその用途
|
EP0541037A3
(en)
*
|
1991-11-06 |
1997-02-26 |
Takeda Chemical Industries Ltd |
Squalene synthetase inhibitory composition and use thereof
|
ES2118967T3
(es)
*
|
1992-05-29 |
1998-10-01 |
Procter & Gamble Pharma |
Compuestos de fosfonato que contienen nitrogeno cuaternario para tratar un metabolismo anormal del calcio y fosfato asi como el calculo y la placa dentales.
|
NZ253524A
(en)
*
|
1992-05-29 |
1997-01-29 |
Procter & Gamble Pharma |
Sulphur-containing phosphonate derivatives and medicaments (for treating abnormal calcium and phosphate metabolism)
|
US5763611A
(en)
*
|
1992-05-29 |
1998-06-09 |
The Procter & Gamble Company |
Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
|
US5391743A
(en)
*
|
1992-05-29 |
1995-02-21 |
Procter & Gamble Pharmaceuticals, Inc. |
Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
|
US5753634A
(en)
*
|
1992-05-29 |
1998-05-19 |
The Procter & Gamble Company |
Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism
|
RU2124019C1
(ru)
*
|
1992-05-29 |
1998-12-27 |
Дзе Проктер энд Гэмбл Фармасьютикалз, Инк. |
Тиозамещенные пиридинилбисфосфоновые кислоты или их фармацевтически приемлемые соли или эфиры, фармацевтическая композиция на их основе и способ лечения
|
DE69324684T2
(de)
*
|
1992-06-30 |
1999-11-25 |
Procter & Gamble Pharma |
Arzneimitteln zur behandlung von arthritis die phosphonate und nsaids enthalten
|
US5618804A
(en)
*
|
1992-07-10 |
1997-04-08 |
Toray Industries, Inc. |
Methanediphosphonic acid derivative, process for production thereof and use for pharmaceuticals
|
GB9215433D0
(en)
*
|
1992-07-21 |
1992-09-02 |
Cmb Foodcan Plc |
Apparatus for stripping a drawn article from a punch
|
FR2694558B1
(fr)
*
|
1992-08-05 |
1994-10-28 |
Sanofi Elf |
Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.
|
DE69313291D1
(de)
*
|
1992-08-07 |
1997-09-25 |
Upjohn Co |
Phosphonoessigsäure und ester als antientzündungsmittel
|
WO1994009017A1
(en)
*
|
1992-10-09 |
1994-04-28 |
The Upjohn Company |
Pyrimidine bisphosphonate esters and (alkoxymethylphosphinyl)alkyl phosphonic acids as anti-inflammatories
|
JPH06135976A
(ja)
*
|
1992-10-30 |
1994-05-17 |
Toray Ind Inc |
メタンジホスホン酸誘導体、その製造方法およびその医薬用途
|
US5332728A
(en)
*
|
1992-11-23 |
1994-07-26 |
Bristol-Myers Squibb Company |
Method for treating a fungal infection
|
AU670337B2
(en)
|
1992-11-30 |
1996-07-11 |
Novartis Ag |
Use of certain methanebisphosphonic acid derivatives in fracture healing
|
US6399592B1
(en)
|
1992-12-23 |
2002-06-04 |
Merck & Co., Inc. |
Bishphosphonate/estrogen synergistic therapy for treating and preventing bone loss
|
CN1038033C
(zh)
*
|
1993-02-25 |
1998-04-15 |
东丽株式会社 |
甲基二膦酸化合物的制备方法
|
FR2703590B1
(fr)
*
|
1993-04-05 |
1995-06-30 |
Sanofi Elf |
Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
|
US5854227A
(en)
*
|
1994-03-04 |
1998-12-29 |
Hartmann; John F. |
Therapeutic derivatives of diphosphonates
|
US20010007863A1
(en)
*
|
1998-06-18 |
2001-07-12 |
Merck & Co., Inc. |
Wet granulation formulation for bisphosphonic acids
|
AU699641B2
(en)
*
|
1994-08-24 |
1998-12-10 |
Toray Industries, Inc. |
Process for production of methanediphosphonic acid compound
|
WO1996039107A1
(en)
|
1995-06-06 |
1996-12-12 |
Merck & Co., Inc. |
Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices
|
US5880111A
(en)
*
|
1995-06-07 |
1999-03-09 |
Farcasiu; Dan |
Therapeutic derivations of diphosphonates
|
ES2239774T3
(es)
*
|
1995-09-29 |
2005-10-01 |
Novartis Ag |
Metodo de tratamiento de la enfermedad navicular en caballos.
|
WO1998015560A1
(en)
*
|
1996-10-09 |
1998-04-16 |
Elizanor Biopharmaceuticals, Inc. |
Diphosphonate therapeutic compounds
|
US8586781B2
(en)
|
1998-04-02 |
2013-11-19 |
Mbc Pharma, Inc. |
Bone targeted therapeutics and methods of making and using the same
|
DK1112275T3
(da)
|
1998-09-09 |
2003-11-24 |
Metabasis Therapeutics Inc |
Hidtil ukendte heteroaromatiske inhibitorer for fructose-1,6-bisphosphatase
|
FR2784031B1
(fr)
*
|
1998-10-02 |
2002-02-01 |
Sanofi Elf |
Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries
|
US6579860B1
(en)
*
|
1998-12-25 |
2003-06-17 |
Toray Industries, Inc. |
Interleukin-6 production inhibitors
|
DE60041876D1
(de)
|
1999-07-23 |
2009-05-07 |
Philadelphia Children Hospital |
Polyurethanderivatzusammensetzungen und Verfahren zu ihrer Herstellung
|
AR021347A1
(es)
*
|
1999-10-20 |
2002-07-17 |
Cipla Ltd |
Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
|
WO2001044257A1
(en)
*
|
1999-12-17 |
2001-06-21 |
Ariad Pharmaceuticals, Inc. |
Proton pump inhibitors
|
IL149887A0
(en)
*
|
1999-12-22 |
2002-11-10 |
Metabasis Therapeutics Inc |
Novel bisamidate phosphonate prodrugs
|
US6677320B2
(en)
|
2000-01-20 |
2004-01-13 |
Hoffmann-La Roches Inc. |
Parenteral bisphosphonate composition with improved local tolerance
|
US7563774B2
(en)
*
|
2000-06-29 |
2009-07-21 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
|
EP1383510B1
(en)
*
|
2001-04-10 |
2012-10-17 |
MBC Pharma, Inc. |
Bisphosphonate conjugates and methods of making and using the same
|
US6558702B2
(en)
*
|
2001-04-13 |
2003-05-06 |
Alkermes Controlled Therapeutics, Inc. |
Method of modifying the release profile of sustained release compositions
|
US20060269602A1
(en)
*
|
2001-04-13 |
2006-11-30 |
Dasch James R |
Method of modifying the release profile of sustained release compositions
|
TWI315982B
(en)
*
|
2001-07-19 |
2009-10-21 |
Novartis Ag |
Combinations comprising epothilones and pharmaceutical uses thereof
|
JP2005514400A
(ja)
*
|
2001-12-21 |
2005-05-19 |
ザ プロクター アンド ギャンブル カンパニー |
骨疾患の治療方法
|
US20050070504A1
(en)
*
|
2001-12-21 |
2005-03-31 |
The Procter & Gamble Co. |
Risedronate compositions and their methods of use
|
JP4502641B2
(ja)
*
|
2002-01-24 |
2010-07-14 |
ティルタン ファーマ リミテッド |
抗癌組み合わせおよびその使用方法
|
CA2480814A1
(en)
*
|
2002-04-05 |
2003-10-23 |
Merck & Co., Inc. |
Method for inhibiting bone resorption with an alendronate and vitamin d formulation
|
ATE376444T1
(de)
*
|
2002-05-10 |
2007-11-15 |
Hoffmann La Roche |
Ibandronsäure zur behandlung und vorbeugung von osteoporose
|
US20060258726A1
(en)
*
|
2002-06-06 |
2006-11-16 |
Xavier Billot |
1,5-Disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
|
WO2004029117A2
(en)
*
|
2002-09-26 |
2004-04-08 |
The Children's Hospital Of Philadelphia |
Derivatized polyurethane compositions which exhibit enhanced stability in biological systems and methods of making the same
|
US20040138180A1
(en)
*
|
2002-10-03 |
2004-07-15 |
Barr Laboratories, Inc. |
Bisphosphonate composition and process for the preparation thereof
|
BR0309691A
(pt)
|
2002-12-20 |
2005-08-02 |
Hoffmann La Roche |
Formulação de ibandronato em alta dose
|
WO2005007034A1
(en)
|
2003-07-08 |
2005-01-27 |
The Children's Hospital Of Philadelphia |
Steroid lipid-modified polyurethane as an implantable biomaterial, the preparation and uses thereof
|
CN1839114A
(zh)
|
2003-08-21 |
2006-09-27 |
默克弗罗斯特加拿大有限公司 |
组织蛋白酶半胱氨酸蛋白酶抑制剂
|
AU2004273672A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Wisconsin Alumni Research Foundation |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate
|
US20050261250A1
(en)
*
|
2004-05-19 |
2005-11-24 |
Merck & Co., Inc., |
Compositions and methods for inhibiting bone resorption
|
CA2566798A1
(en)
|
2004-05-24 |
2005-12-08 |
The Procter & Gamble Company |
Enteric solid oral dosage form of bisphosphonate containing a chelating agent
|
UA87854C2
(en)
|
2004-06-07 |
2009-08-25 |
Мерк Энд Ко., Инк. |
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
|
BRPI0514372A
(pt)
*
|
2004-08-18 |
2008-06-10 |
Metabasis Therapeutics Inc |
inibidores de tiazol de frutose 1, 6-bisfosfatase
|
US8697139B2
(en)
|
2004-09-21 |
2014-04-15 |
Frank M. Phillips |
Method of intervertebral disc treatment using articular chondrocyte cells
|
WO2007046842A2
(en)
|
2005-03-02 |
2007-04-26 |
Merck & Co., Inc. |
Composition for inhibition of cathepsin k
|
EP1865928A1
(en)
*
|
2005-03-17 |
2007-12-19 |
Elan Pharma International Limited |
Nanoparticulate biphosphonate compositions
|
DE602006006663D1
(de)
*
|
2005-03-24 |
2009-06-18 |
Medtronic Inc |
Modifizierung von thermoplastischen polymeren
|
EP2222636B1
(en)
|
2007-12-21 |
2013-04-10 |
Ligand Pharmaceuticals Inc. |
Selective androgen receptor modulators (sarms) and uses thereof
|
EP2324041A4
(en)
|
2008-08-13 |
2012-06-13 |
Targanta Therapeutics Corp |
PHOSPHONIZED RIFAMYCINS AND ITS APPLICATION FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS
|
US20120100206A1
(en)
|
2009-06-11 |
2012-04-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Targeted liposomes comprising n-containing bisphosphonates and uses thereof
|
FR2954320B1
(fr)
|
2009-12-17 |
2012-06-15 |
Cll Pharma |
Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
|
EP2675440B1
(en)
|
2011-02-14 |
2020-03-25 |
Merck Sharp & Dohme Corp. |
Cathepsin cysteine protease inhibitors
|
PL2731591T3
(pl)
|
2011-07-13 |
2021-05-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Liposomy zawierające bisfosfonian i środek amfipatyczny w wyniku ko-enkapsulacji
|
CA2843885C
(en)
|
2011-08-01 |
2020-03-10 |
Mbc Pharma, Inc. |
Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
|
GB201200868D0
(en)
|
2012-01-19 |
2012-02-29 |
Depuy Int Ltd |
Bone filler composition
|
WO2015051479A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Cathepsin cysteine protease inhibitors
|
EP3055314B1
(en)
|
2013-10-08 |
2018-09-12 |
Merck Sharp & Dohme Corp. |
Cathepsin cysteine protease inhibitors
|
WO2015120580A1
(en)
|
2014-02-11 |
2015-08-20 |
Merck Sharp & Dohme Corp. |
Cathepsin cysteine protease inhibitors
|
PL407922A1
(pl)
|
2014-04-16 |
2015-10-26 |
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością |
Nowe bisfosfoniany i ich zastosowanie
|
SG11201609050UA
(en)
|
2014-05-30 |
2016-12-29 |
Pfizer |
Carbonitrile derivatives as selective androgen receptor modulators
|
WO2023275715A1
(en)
|
2021-06-30 |
2023-01-05 |
Pfizer Inc. |
Metabolites of selective androgen receptor modulators
|